Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
NEUROLOGY
June 16, 2023
Alzheimer’s Disease and Current Treatment
Two approved monoclonal antibodies have demonstrated that removing beta-amyloids from the brain reduces cognitive and functional decline in early stages.
June 16, 2023
Tardive Dyskinesia
May 19, 2023
Adderall 1 mg/mL Oral Suspension
May 19, 2023
Drug Therapy for Obsessive-Compulsive Disorder
March 17, 2023
Current Monoclonal Antibody Options for Multiple Sclerosis
March 17, 2023
Pain-Management Approaches for Peripheral Neuropathy
February 17, 2023
Stroke Rates and Hospitalizations
January 26, 2023
Assisted Reproduction Technology and Risk of Developing MS
January 26, 2023
Study Reveals Gender Differences in Cluster Headaches
January 19, 2023
Lamotrigine 1 mg/mL Compounded Oral Suspension, USP
January 19, 2023
Community Pharmacists’ Role in the Treatment of Epilepsy
January 19, 2023
Risks and Considerations for Epilepsy
January 19, 2023
Managing Glaucoma
Load More
X
September 2023
In This Issue
Digital Magazine
Archives
Subscription
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Aducanumab for the Treatment of Alzheimer’s Disease
The Pharmacologic Management of Migraine
×
Full Image